Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Illegal Botox Scammers
The FDA recently released a report about an investigation of 210 health care professionals across the United States who purposely injected an unapproved, cheaper substitute toxin for FDA-approved Botox Cosmetic which resulted in paralysis of several patients. For more information please visit: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048377.htm
Learn More

Update on potential for acute pancreatitis in patients using Byetta
Today the FDA issued an update on the reports of acute pancreatitis in patients taking Byetta, a medicine given by subcutaneous injection to help treat people with type 2 diabetes. Since the October 2007 alert, the FDA has received 6 additional reports of acute pancreatitis thought to be associated with Byetta use. Acute pancreatitis is the sudden inflammation of the pancreas that may be mild or life threatening but that usually subsides. Symptoms of pancreatitis include persistent severe abdominal pain that can radiate to the back and may be accompanied by nausea and vomiting. For more information please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124713.htm
Learn More

Date Published Title Drug Source
2008-08-21 Illegal Botox Scammers Onabotulinumtoxina FDA
2008-08-18 Update on potential for acute pancreatitis in patients using Byetta Exenatide FDA
2008-08-15 Hormone replacement therapy (HRT) increases risk for non-cancerous breast disease and stroke Estrogen with Testosterone MediGuard CRT
2008-08-14 Weight gain associated with use of antipsychotics Aripiprazole MediGuard CRT
2008-08-14 Weight gain associated with use of antipsychotics Olanzapine MediGuard CRT
2008-08-14 Weight gain associated with use of antipsychotics Quetiapine MediGuard CRT
2008-08-14 Weight gain associated with use of antipsychotics Risperidone MediGuard CRT
2008-08-14 Weight gain associated with use of antipsychotics Ziprasidone MediGuard CRT
2008-08-13 Angioedema and ACE inhibitors Amlodipine Besylate with Benazepril MediGuard CRT
2008-08-13 Angioedema and ACE inhibitors Lexxel MediGuard CRT
2008-08-13 Angioedema and ACE inhibitors Trandolapril with Verapamil MediGuard CRT
2008-08-13 Use of alendronate (Fosamax) by women associated with an increased risk of an abnormal heart rhythm Alendronate MediGuard CRT
2008-08-13 Use of alendronate (Fosamax) by women associated with an increased risk of an abnormal heart rhythm Alendronate and Vitamin D MediGuard CRT
2008-08-13 Heart risks associated with celecoxib (Celebrex) Celecoxib MediGuard CRT
2008-08-13 Hormone replacement therapy (HRT) increases risk for non-cancerous breast disease and stroke Estrogens Conjugated MediGuard CRT
2008-08-13 Hormone replacement therapy (HRT) increases risk for non-cancerous breast disease and stroke Estrogens Conjugated with Medroxyprogesterone MediGuard CRT
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women Calcium Carbonate MediGuard CRT
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women Calcium Citrate MediGuard CRT
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women MediGuard CRT
2008-08-13 Heart risks with calcium supplements in healthy post-menopausal women MediGuard CRT
Back to Consumer Med Safety